An Essential Update in Preventative Cardiology in the Time of COVID-19
To register for notification when the 94th Annual Clinical Reviews Course opens visit: https://mayocl.in/2GvecAd
Guest: Stephen L. Kopecky, M.D.
With underlying cardiovascular disease as the most lethal comorbidity to have in association with COVID-19, what have we learned about how SARS-CoV-2 affects the heart and what correlation is seen between patients with cardiometabolic disorders and preventative health measures? Dr. Stephen Kopecky shares lessons learned for all cardiologists, all caregivers, and all patients.
“The cardiovascular risk profile that we use from the American College of Cardiology, from the American Heart Association, looks at hypertension, looks at smoking, looks at diabetes, and looks at lipids. That risk profile predicts cardiovascular complications. So it not only predicts disease but it predicts the complications of COVID infection.”
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
